At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Alprazolam and Simulated Driving Performance: Next Day Effects
In Brief
A Phase 4 clinical trial evaluating Alprazolam 2mg (2ALP/PLC), Alprazolam 1mg (1ALP/PLC), and 4 other interventions for Psychomotor Impairment. Completed, enrolled 15 participants across 1 site.
Detailed Summary
This study evaluates the effect of anxiety drugs taken at night on the ability to drive a car the next day. Participants will receive alprazolam, placebo, or zolpidem at night before bed or in the morning before using a driving simulator to assess impairment.
Study Details
Timeline
Interventions
2mg alprazolam administered at night, placebo administered in the morning.
1mg alprazolam administered at night, placebo administered in the morning.
0.5mg alprazolam administered at night, placebo administered in the morning.
10mg alprazolam administered at night, placebo administered in the morning.
Placebo administered at night, placebo administered in the morning.
Placebo administered at night, 1mg alprazolam administered in the morning.